<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://ecam.oxfordjournals.org">
<title>Evidence-based Complementary and Alternative Medicine - recent issues</title>
<link>http://ecam.oxfordjournals.org</link>
<description>Evidence-based Complementary and Alternative Medicine - RSS feed of recent issues (covers the latest 3 issues, including the current issue) </description>
<prism:eIssn>1741-4288</prism:eIssn>
<prism:publicationName>Evidence-based Complementary and Alternative Medicine</prism:publicationName>
<prism:issn>1741-427X</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/3/279?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/3/283?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/3/297?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/3/305?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/3/315?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/3/317?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/3/325?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/3/331?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/3/343?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/3/351?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/3/357?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/3/365?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/3/375?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/3/379?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/3/393?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/3/399?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/3/407?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/3/415?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/129?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/133?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/141?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/153?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/159?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/165?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/175?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/185?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/195?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/203?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/211?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/219?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/227?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/233?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/239?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/247?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/257?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/265?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/271?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/2/277?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/3?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/11?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/19?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/31?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/41?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/49?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/51?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/57?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/65?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/77?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/85?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/91?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/99?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/107?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/113?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/6/1/123?rss=1" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/3/279?rss=1">
<title><![CDATA[eCAM: A Closer Look at Clinical Analyses]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/3/279?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Cooper, E. L.]]></dc:creator>
<dc:date>Wed, 05 Aug 2009 06:45:29 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep099</dc:identifier>
<dc:title><![CDATA[eCAM: A Closer Look at Clinical Analyses]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>281</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>279</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/3/283?rss=1">
<title><![CDATA[Novel Diagnosis of Lyme Disease: Potential for CAM Intervention]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/3/283?rss=1</link>
<description><![CDATA[
<p>Lyme disease (LD) is the most common tick-borne disease in the northern hemisphere, producing a wide range of disabling effects on multiple human targets, including the skin, the nervous system, the joints and the heart. Insufficient clinical diagnostic methods, the necessity for prompt antibiotic treatment along with the pervasive nature of infection impel the development and establishment of new clinical diagnostic tools with increased accuracy, sensitivity and specificity. The goal of this article is 4-fold: (i) to detail LD infection and pathology, (ii) to review prevalent diagnostic methods, emphasizing inherent problems, (iii) to introduce the usage of <I>in vivo</I> induced antigen technology (IVIAT) in clinical diagnostics and (iv) to underscore the relevance of a novel comprehensive LD diagnostic approach to practitioners of Complementary and Alternative Medicine (CAM). Utilization of this analytical method will increase the accuracy of the diagnostic process and abridge the time to treatment, with antibiotics, herbal medicines and nutritional supplements, resulting in improved quality of care and disease prognosis.</p>
]]></description>
<dc:creator><![CDATA[Vojdani, A., Hebroni, F., Raphael, Y., Erde, J., Raxlen, B.]]></dc:creator>
<dc:date>Wed, 05 Aug 2009 06:45:29 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem138</dc:identifier>
<dc:title><![CDATA[Novel Diagnosis of Lyme Disease: Potential for CAM Intervention]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>295</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>283</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/3/297?rss=1">
<title><![CDATA[Cost Effectiveness of Natural Health Products: A Systematic Review of Randomized Clinical Trials]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/3/297?rss=1</link>
<description><![CDATA[
<p>Health care spending in North America is consuming an ever-increasing share of Gross Domestic Product (GDP). A large proportion of alternative health care is consumed in the form of natural health products (NHPs). The question of whether or not NHPs may provide a cost-effective choice in the treatment of disease is important for patients, physicians and policy makers. The objective of this study was to conduct a systematic review of the literature in order to find, appraise and summarize high-quality studies that explore the cost effectiveness of NHPs as compared to conventional medicine. The following databases were searched independently in duplicate from inception to January 1, 2006: EMBASE, MEDLINE, CINAHL, BioethicsLine, Wilson General Science abstracts, EconLit, Cochrane Library, ABI/Inform and SciSearch. To be included in the review, trials had to be randomized, assessed for some measure of cost effectiveness and include the use of NHPs as defined by the Natural Health Products Directorate. Studies dealing with diseases due to malnutrition were excluded from appraisal. The pooled searches unveiled nine articles that fit the inclusion/exclusion criteria. The conditions assessed by the studies included three on postoperative complications, two on cardiovascular disease, two on gastrointestinal disorders, one on critically ill patients and one on urinary tract infections. Heterogeneity between the studies was too great to allow for meta-analysis of the results. The use of NHPs shows evidence of cost effectiveness in relation to postoperative surgery but not with respect to the other conditions assessed. In conclusion, NHPs may be of use in preventing complications associated with surgery. The cost effectiveness of some NHPs is encouraging in certain areas but needs confirmation from further research.</p>
]]></description>
<dc:creator><![CDATA[Kennedy, D. A., Hart, J., Seely, D.]]></dc:creator>
<dc:date>Wed, 05 Aug 2009 06:45:29 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem167</dc:identifier>
<dc:title><![CDATA[Cost Effectiveness of Natural Health Products: A Systematic Review of Randomized Clinical Trials]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>304</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>297</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/3/305?rss=1">
<title><![CDATA[Ten Years Evidence-based High-Tech Acupuncture-A Short Review of Centrally Measured Effects (Part II)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/3/305?rss=1</link>
<description><![CDATA[
<p>The assessment of acupuncture-induced effects on brain function is crucial. Ultrasound-assisted brain function monitoring and bioelectrical methods as well as near infrared spectroscopic procedures and functional magnetic resonance investigations form the basis for the latest scientific examination methods for acupuncture research. The laserneedle acupuncture, which was examined scientifically for the first time in Graz, represents a new painless and non-invasive acupuncture method. In this way, individual combinations of acupuncture points can be stimulated simultaneously according to traditional Chinese medicine. In the context of double-blind studies, effects in the brain could be demonstrated in a reproducible manner for the first time. This second part of the short review article summarizes some of the centrally measured effects of acupuncture obtained at the Medical University of Graz within the last 10 years.</p>
]]></description>
<dc:creator><![CDATA[Litscher, G.]]></dc:creator>
<dc:date>Wed, 05 Aug 2009 06:45:29 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem169</dc:identifier>
<dc:title><![CDATA[Ten Years Evidence-based High-Tech Acupuncture-A Short Review of Centrally Measured Effects (Part II)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>314</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>305</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/3/315?rss=1">
<title><![CDATA[The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/3/315?rss=1</link>
<description><![CDATA[
<p>Maca, a plant native to the Peruvian highlands, contains (1R,3S)-1-methyl-1,2,3,4-tetrahydro-&beta;-carboline-3-carboxylic acid (MTCA). The family of the tetrahydro-&beta;-carbolines has been associated with both biologically helpful and harmful compounds. We present evidence that MTCA is a natural constituent of Maca, and on consumption no toxicity is found. This suggests that, when consumed as multi-component, MTCA may loose its adversity as drug action.</p>
]]></description>
<dc:creator><![CDATA[Gonzales, G. F., Gonzales-Castaneda, C.]]></dc:creator>
<dc:date>Wed, 05 Aug 2009 06:45:29 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen041</dc:identifier>
<dc:title><![CDATA[The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>316</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>315</prism:startingPage>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/3/317?rss=1">
<title><![CDATA[Ficus racemosa Stem Bark Extract: A Potent Antioxidant and a Probable Natural Radioprotector]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/3/317?rss=1</link>
<description><![CDATA[
<p>Ethanol extract (FRE) and water extract (FRW) of <I>Ficus racemosa</I> (family: Moraceae) were subjected to free radical scavenging both by steady state and time resolved methods such as nanosecond pulse radiolysis and stopped-flow spectrophotometric analyses. FRE exhibited significantly higher steady state antioxidant activity than FRW. FRE exhibited concentration dependent DPPH, ABTS<sup>&bull;&ndash;</sup>, hydroxyl radical and superoxide radical scavenging and inhibition of lipid peroxidation with IC<SUB>50</SUB> comparable with tested standard compounds. <I>In vitro</I> radioprotective potential of FRE was studied using micronucleus assay in irradiated Chinese hamster lung fibroblast cells (V79). Pretreatment with different doses of FRE 1h prior to 2 Gy -radiation resulted in a significant (<I>P</I> &lt; 0.001) decrease in the percentage of micronucleated binuclear V79 cells. Maximum radioprotection was observed at 20 &micro;g/ml of FRE. The radioprotection was found to be significant (<I>P</I> &lt; 0.01) when cells were treated with optimum dose of FRE (20 &micro;g/ml) 1 h prior to 0.5, 1, 2, 3 and 4 Gy -irradiation compared to the respective radiation controls. The cytokinesis-block proliferative index indicated that FRE does not alter radiation induced cell cycle delay. Based on all these results we conclude that the ethanol extract of <I>F. racemosa</I> acts as a potent antioxidant and a probable radioprotector.</p>
]]></description>
<dc:creator><![CDATA[Veerapur, V. P., Prabhakar, K. R., Parihar, V. k., Kandadi, M. R., Ramakrishana, S., Mishra, B., Satish Rao, B. S., Srinivasan, K. K., Priyadarsini, K. I., Unnikrishnan, M. K.]]></dc:creator>
<dc:date>Wed, 05 Aug 2009 06:45:29 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem119</dc:identifier>
<dc:title><![CDATA[Ficus racemosa Stem Bark Extract: A Potent Antioxidant and a Probable Natural Radioprotector]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>324</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>317</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/3/325?rss=1">
<title><![CDATA[Modified Wendan Decoction can Attenuate Neurotoxic Action Associated with Alzheimer's Disease]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/3/325?rss=1</link>
<description><![CDATA[
<p>We observed the effect of modified Wendan decoction (modified Wen-Dan-Tang) on a cellular model of Alzheimer's disease. Amyloid beta (A&beta;) 25&ndash;35 segment neurotoxin was employed to induce a PC12 cellular model of Alzheimer's disease. After modified Wendan decoction was fed to rats, the serum containing medicine was prepared and changes in cell morphology observed. Cell mortality and survival rate was examined by trypan blue stain assay and MTT method and caspase-3 expression was detected by western blot, while cell apoptosis was examined by flow cytometry. Cell morphology of prepared serum group was better than that of controls, and cell survival rate in prepared serum group was higher than that in control (<I>P</I> &lt; 0.01 or <I>P</I> &lt; 0.05). Cell mortality, caspase-3 expression and apoptosis rate in prepared serum group were lower than that in control (<I>P</I> &lt; 0.01 or <I>P</I> &lt; 0.05). We conclude that Modified Wendan Decoction can attenuate the neurotoxicity of A&beta; 25&ndash;35 and rescue neurons via suppressing apoptotic process.</p>
]]></description>
<dc:creator><![CDATA[Liu, P., Zhao, L., Zhang, S.-L., Xiang, J.-Z.]]></dc:creator>
<dc:date>Wed, 05 Aug 2009 06:45:29 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem103</dc:identifier>
<dc:title><![CDATA[Modified Wendan Decoction can Attenuate Neurotoxic Action Associated with Alzheimer's Disease]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>330</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>325</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/3/331?rss=1">
<title><![CDATA[Phytic Acid Exposure Alters AflatoxinB1-induced Reproductive and Oxidative Toxicity in Albino Rats (Rattus norvegicus)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/3/331?rss=1</link>
<description><![CDATA[
<p>The increased use of feed in Egypt's aquaculture and animal industries raises concerns about the possible presence of mycotoxins in feedstuffs. The use of alternative medicine, such as botanicals and nutritional supplements, has become popular with inflammatory cases. The present study aimed to testify the role played by phytic acid (IP6) in enhancing the reproductive and oxidative toxicity induced in aflatoxinB1 (AFB1) treated white male albino rats (<I>Rattus norvegicus</I>) throughout treatment and withdrawal periods. One hundred and twenty white male albino rats were grouped into four groups. Group 1, was injected with 300 &micro;g kg<sup>&ndash;1</sup> body wt of AFB1 once every 3 days for 15 days and left uninjected for another 15 days to study the withdrawal effect. Group 2, was injected with 300 &micro;g kg<sup>&ndash;1</sup> body wt of AFB1 once every 3 days for 15 days and treated simultaneously with IP6 daily for another 15 days. Group 3, was treated daily with IP6 (40 mg kg<sup>&ndash;1</sup> body wt) for 15 days and with no treatment for other 15 days. Group 4, injected with equivalent volume of sterile phosphate buffer saline solution as a control group. Sera were taken at the experimental intervals and assayed for testosterone hormone, follicular-stimulating hormone (FSH) and luteinizing hormone (LH) to determine the toxicological impact of AFB1 and the possibility of amelioration by phytic acid on the reproductive performance of the studied animal. The effects of AFB1 treatment on the absolute and relative weight of testis as well as its histopathologic effect on the testis and the possibility of amelioration by IP6 treatment were evaluated. The activities of enzymatic and non-enzymatic anti-oxidants, in addition to lipid peroxidation were measured in the testis&rsquo; homogenate of AFB1-treated rats. A decrease in sex hormone levels, an increase in testicular lipid peroxidation product levels and a significant decrease in testicular glutathione content, catalase and total peroxidase and superoxide dismutase activities were recorded. The histopathologic alterations revealed a degeneration and highly mitotic division within the spermatogenic nuclei, in addition to some karyomegaly and nuclear pyknosis. It is concluded that the reduction in the toxicity of free radicals by phytic acid might be responsible for the protective influence observed.</p>
]]></description>
<dc:creator><![CDATA[Abu El-Saad, A. S., Mahmoud, H. M.]]></dc:creator>
<dc:date>Wed, 05 Aug 2009 06:45:29 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem137</dc:identifier>
<dc:title><![CDATA[Phytic Acid Exposure Alters AflatoxinB1-induced Reproductive and Oxidative Toxicity in Albino Rats (Rattus norvegicus)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>341</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>331</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/3/343?rss=1">
<title><![CDATA[Crocus Sativus L. (Saffron) Extract and its Active Constituents (Crocin and Safranal) on Ischemia-Reperfusion in Rat Skeletal Muscle]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/3/343?rss=1</link>
<description><![CDATA[
<p>Saffron and its constituents have been shown to decrease ischemia-reperfusion (I/R) injury in kidney or brain tissues. In this study, the effects of saffron ethanolic extract and its constituents, crocin and safranal, were evaluated in skeletal muscle during I/R injury. Hind limb ischemia was induced using clamping the common femoral artery and vein. After 2 h ischemia, the clamp of the femoral vessels of animals was taken off and the animal underwent 1h reperfusion. Muscle injuries were evaluated by recording of the electromyographic (EMG) potentials and performing some biochemical analysis including thiobarbituric acid reactive substances (TBARS), total sulfhydryl (SH) groups and antioxidant capacity of muscle (using FRAP assay). The ethanolic extract of saffron (5, 20 and 80 mg kg<sup>&ndash;1</sup>), crocin (50, 200 and 400 mg kg<sup>&ndash;1</sup>), safranal (0.1, 0.25 and 0.5 ml kg<sup>&ndash;1</sup>) and normal saline (10 ml kg<sup>&ndash;1</sup>) were administered intraperitoneally 1 h prior reperfusion. The average peak-to-peak amplitude during I/R was significantly increased in extract, crocin and safranal groups in comparison with control-ischemic group. Following saffron, crocin and safranal administration, the total SH contents and antioxidant capacity were elevated in muscle flap. The MDA level was declined significantly in test groups. It is concluded that saffron extract and its constituents show a protective effect against lower limb I/R in rat.</p>
]]></description>
<dc:creator><![CDATA[Hosseinzadeh, H., Modaghegh, M. H., Saffari, Z.]]></dc:creator>
<dc:date>Wed, 05 Aug 2009 06:45:29 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem125</dc:identifier>
<dc:title><![CDATA[Crocus Sativus L. (Saffron) Extract and its Active Constituents (Crocin and Safranal) on Ischemia-Reperfusion in Rat Skeletal Muscle]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>350</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>343</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/3/351?rss=1">
<title><![CDATA[Evaluation of the Wound-healing Activity of Ethanolic Extract of Morinda citrifolia L. Leaf]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/3/351?rss=1</link>
<description><![CDATA[
<p><I>Morinda citrifolia</I> L. (noni) is one of the most important traditional Polynesian medicinal plants. The primary indigenous use of this plant appears to be of the leaves, as a topical treatment for wound healing. The ethanol extract of noni leaves (150 mg kg<sup>&ndash;1</sup> day<sup>&ndash;1</sup>) was used to evaluate the wound-healing activity on rats, using excision and dead space wound models. Animals were randomly divided into two groups of six for each model. Test group animals in each model were treated with the ethanol extract of noni orally by mixing in drinking water and the control group animals were maintained with plain drinking water. Healing was assessed by the rate of wound contraction, time until complete epithelialization, granulation tissue weight and hydoxyproline content. On day 11, the extract-treated animals exhibited 71% reduction in the wound area when compared with controls which exhibited 57%. The granulation tissue weight and hydroxyproline content in the dead space wounds were also increased significantly in noni-treated animals compared with controls (<I>P</I> &lt; 0.002). Enhanced wound contraction, decreased epithelialization time, increased hydroxyproline content and histological characteristics suggest that noni leaf extract may have therapeutic benefits in wound healing.</p>
]]></description>
<dc:creator><![CDATA[Nayak, B. S., Sandiford, S., Maxwell, A.]]></dc:creator>
<dc:date>Wed, 05 Aug 2009 06:45:29 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem127</dc:identifier>
<dc:title><![CDATA[Evaluation of the Wound-healing Activity of Ethanolic Extract of Morinda citrifolia L. Leaf]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>356</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>351</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/3/357?rss=1">
<title><![CDATA[Improvement of Experimentally Induced Hepatic and Renal Disorders in Rats using Lactic Acid Bacteria-fermented Soybean Extract (BiofermenticsTM)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/3/357?rss=1</link>
<description><![CDATA[
<p>The effects of lactic acid bacteria-fermented soybean extract (Biofermentics<SUP><SMALL><SMALL>TM</SMALL></SMALL></SUP>; BF) on experimental models of hepatic and renal disorders were investigated <I>in vivo</I> and <I>in vitro</I>. In rat, hepatitis induced by feeding of deoxycholic acid (DCA, 0.5 wt/wt, <I>n</I> = 6) or intraperitoneal injection of <scp>d</scp>-galactosamine (GMN, 500 mg/body wt, <I>n</I> = 6), the increase in serum AST (aspartate aminotransferase) and ALT (alanine aminotransferase) levels were inhibited significantly (<I>P</I> &lt; 0.05) by feeding a diet containing 5% dried BF. Moreover, the BF-administered rat group showed lower concentrations of blood urea nitrogen and a larger amount of urine as compared with values in the control group. Pretreatment of primary cell cultures of rat hepatic and renal cells with BF prior to exposure to dichromate (K<SUB>2</SUB>Cr<SUB>2</SUB>O<SUB>7</SUB>) resulted in a marked decrease of dichromate-induced cytotoxicity as evaluated by the leakage of lactate dehydrogenase The levels of dichromate-induced lipid peroxidation, as monitored by malondialdehyde formation, were also reduced by pretreatment of hepatocytes with BF. These results suggest that BF may play a role in hepatic and renal disorders, and may be useful for maintaining health in humans as well.</p>
]]></description>
<dc:creator><![CDATA[Shin, R., Suzuki, M., Mizutani, T., Susa, N.]]></dc:creator>
<dc:date>Wed, 05 Aug 2009 06:45:29 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem126</dc:identifier>
<dc:title><![CDATA[Improvement of Experimentally Induced Hepatic and Renal Disorders in Rats using Lactic Acid Bacteria-fermented Soybean Extract (BiofermenticsTM)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>363</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>357</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/3/365?rss=1">
<title><![CDATA[Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel (Perna canaliculus)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/3/365?rss=1</link>
<description><![CDATA[
<p>A green-lipped mussel (GLM) preparation was evaluated in a randomized, double-controlled and double-blinded clinical trial. It was hypothesized that the treatment effect would be less than that of the positive control (carprofen) but more than that of the negative control (placebo). Forty-five dogs with chronic pain and a radiographic diagnosis of osteoarthritis that were randomly allocated into one of three groups completed the study. All dogs were fed the test products or placebo for 8 weeks. The dogs were evaluated four times, at 4-week intervals. Six different variables were assessed: veterinary-assessed mobility index, two force plate variables, owner-evaluated chronic pain index and pain as well as locomotion visual analogue scales (VASs). Intake of extra carprofen was also evaluated. A chi-squared and a Mann&ndash;Whitney test were used to determine significance between groups. When changed to dichotomous variables, there were more dogs in the GLM than in the placebo group that improved, according to veterinary-assessed mobility, owner-evaluated chronic pain index and pain VAS (<I>P</I> = 0.031, <I>P</I> = 0.025, <I>P</I> = 0.011, respectively). For the same three, the odds ratio and their confidence interval were over one. The extent of improvement was significantly different between the GLM and the control in veterinary-assessed mobility (<I>P</I> = 0.012) and pain VAS (<I>P</I> = 0.004). In conclusion, GLM alleviated chronic orthopedic pain in dogs although it was not as effective as carprofen. As no side-effects were detected, GLM may be beneficial in dogs e.g. when non-steroidal anti-inflammatory drugs cannot be used.</p>
]]></description>
<dc:creator><![CDATA[Hielm-Bjorkman, A., Tulamo, R.-M., Salonen, H., Raekallio, M.]]></dc:creator>
<dc:date>Wed, 05 Aug 2009 06:45:29 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem136</dc:identifier>
<dc:title><![CDATA[Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel (Perna canaliculus)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>373</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>365</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/3/375?rss=1">
<title><![CDATA[Hangekobokuto (Banxia-houpo-tang), a Kampo Medicine that Treats Functional Dyspepsia]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/3/375?rss=1</link>
<description><![CDATA[
<p>Although abdominal bloating is one of the most bothersome symptoms experienced by patients with functional dyspepsia (FD), therapeutic drugs to relieve abdominal bloating have not been established. We investigated the Kampo (Chinese herbal) medicine, Hangekobokuto (Banxia-houpo-tang, HKT) for patients with FD from the standpoint of bowel gas retention. The bowel gas volume calculated from a plain abdominal radiogram (gas volume score, GVS) in FD patients was significantly higher than that in healthy subjects. Two week administration of HKT in the FD patients showed a significant decrease of GVS. Furthermore, gastrointestinal symptoms, especially symptoms of abdominal pain, indigestion and constipation, all of which are closely related to abdominal bloating, improved significantly in FD patients after the administration of HKT. These results suggest that HKT improves abdominal bloating accompanied by the reduction of bowel gas in FD patients.</p>
]]></description>
<dc:creator><![CDATA[Oikawa, T., Ito, G., Hoshino, T., Koyama, H., Hanawa, T.]]></dc:creator>
<dc:date>Wed, 05 Aug 2009 06:45:29 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem101</dc:identifier>
<dc:title><![CDATA[Hangekobokuto (Banxia-houpo-tang), a Kampo Medicine that Treats Functional Dyspepsia]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>378</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>375</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/3/379?rss=1">
<title><![CDATA[How Far Can Ki-energy Reach?--A Hypothetical Mechanism for the Generation and Transmission of Ki-energy]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/3/379?rss=1</link>
<description><![CDATA[
<p>&lsquo;Ki-energy&rsquo;, which can be enhanced through the practice of Nishino Breathing Method, was reported to have beneficial health effects. Although Ki-energy can play an important role in complementary and alternative medicine (CAM), as yet it is unknown how Ki-energy is generated, transmitted through air and received by another individual. We previously proposed that Ki-energy may include near-infrared radiation, and that the wavelength was between 800 and 2700 nm. Since Ki-energy is reflected by a mirror, we believe that the &lsquo;Ki-beam&rsquo; has a small divergence angle. It can also be guided in a desired direction. The acrylic mirror reflection experiment suggests that the wavelength may be between 800 and 1600 nm. Using a linear variable interference filter, we found that Ki-energy may have a peak around 1000 nm. We have also observed that &lsquo;sensitive&rsquo; practitioners responded to Ki sent from a distance of 100 m. All of these results suggest that (i) Ki-energy can be guided as a directional &lsquo;beam&rsquo; with a small divergence angle; (ii) the beam can be reflected by a mirror and (iii) Ki-energy may have a specific wavelength. Since these properties are characteristics of the laser radiation, we propose a quantum physics-based mechanism of &lsquo;Light Amplification by the Stimulated Emission of Radiation&rsquo; (i.e. LASER) for the generation of Ki-energy. Volunteers responded to Ki even with a blindfold. This suggests that the skin must be detecting Ki-energy. We propose that the detector at the skin level may also have the stimulated emission mechanism, which amplifies the weak incident infrared radiation.</p>
]]></description>
<dc:creator><![CDATA[Ohnishi, S. T., Ohnishi, T.]]></dc:creator>
<dc:date>Wed, 05 Aug 2009 06:45:29 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem102</dc:identifier>
<dc:title><![CDATA[How Far Can Ki-energy Reach?--A Hypothetical Mechanism for the Generation and Transmission of Ki-energy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>391</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>379</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/3/393?rss=1">
<title><![CDATA[Effective Application of Knowledge Management in Evidence-based Chinese Medicine: A Case Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/3/393?rss=1</link>
<description><![CDATA[
<p>Chinese medicine (CM) practice, as a knowledge-based industry, has not embraced knowledge management (KM) techniques widely. However, KM may facilitate the adaptation and promotion of evidence-based CM. A KM framework was introduced to its activities in evidence-based CM through the development of a CM portal. A codification strategy was used to codify and store knowledge systematically in a database. Several approaches were developed and implemented to address specific needs for CM such as centralizing the information, encouraging collective efforts, promoting integration of explicit and tacit knowledge, and developing a flexible technology and support system. Following the established KM framework, the RMIT Chinese Medicine Portal (<inter-ref locator="www.chinese-medicine.com.au" locator-type="url">www.chinese-medicine.com.au</inter-ref>) was built up with four major components: organizational knowledge, knowledge workers, KM processes and information technology. Knowledge on Chinese herbs was classified into core, advanced and innovative categories, which involved the development of the monograph template. A working group was organized including CM, pharmacology and information technology professionals to implement this proposal with following sequential development stages: knowledge creation/acquisition, storage/organization, distribution and application. User interface and web language were also defined and accomplished. This case study demonstrates the applicability of KM in evidence-based CM through a multidisciplinary collaboration, such as, an effective collaboration between CM and information technology. The study also shows the potential of KM application in other disciplines of complementary and alternative medicine.</p>
]]></description>
<dc:creator><![CDATA[Yang, A. W., Allan, G., Li, C. G., Xue, C. C.]]></dc:creator>
<dc:date>Wed, 05 Aug 2009 06:45:29 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem124</dc:identifier>
<dc:title><![CDATA[Effective Application of Knowledge Management in Evidence-based Chinese Medicine: A Case Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>398</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>393</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/3/399?rss=1">
<title><![CDATA[Turo (Qi Dance) Training Attenuates Psychological Symptoms and Sympathetic Activation Induced by Mental Stress in Healthy Women]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/3/399?rss=1</link>
<description><![CDATA[
<p>Vagal withdrawal and sympathetic overactivity accompany various types of stress. Qi training is reported to reduce sympathetic hyper-reactivity in a stressful situation. Turo, which is a type of dance that uses the Meridian Qi System, may reduce the psychological symptoms induced by an imbalance of the autonomic nervous system (ANS). We observed whether Turo training alters psychopathological and psychological symptoms using the Symptom Checklist 90-Revision (SCL-90-R) and examined whether it attenuates the stress response to mental stress in healthy adolescent females using the power spectrum analysis of heart rate variability (HRV). Twenty-one subjects received Turo training and 27 subjects were trained with mimicking movements. The SCL-90-R was measured before and after the 2-month training period. Heart rate (HR), total power (TP) and the LF/HF ratio of HRV were compared between the Turo and control groups during and after mental stress. The somatization and hostility subscales of the SCL-90-R of the Turo group were significantly lower than those of the control group after 2 months. The increases in HR and the LF/HF ratio of HRV induced by the stress test were significantly lower in the Turo group than in the control group. The TP of the Turo group was significantly higher than that of the control group. The psychological symptoms and sympathetic activation induced by the artificial stress were significantly reduced by the Turo training. These findings suggest that Turo training can play a critical role in attenuating psychological symptoms and stress-induced sympathetic activation.</p>
]]></description>
<dc:creator><![CDATA[Lee, H.-J., Chae, Y., Park, H.-J., Hahm, D.-H., An, K., Lee, H.]]></dc:creator>
<dc:date>Wed, 05 Aug 2009 06:45:29 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem120</dc:identifier>
<dc:title><![CDATA[Turo (Qi Dance) Training Attenuates Psychological Symptoms and Sympathetic Activation Induced by Mental Stress in Healthy Women]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>405</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>399</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/3/407?rss=1">
<title><![CDATA[Brief Homeopathic Pathogenetic Experimentation: A Unique Educational Tool in Brazil]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/3/407?rss=1</link>
<description><![CDATA[
<p>In homeopathy, many difficulties are encountered in understanding theoretical presuppositions because they represent different paradigms from those of hegemonic science. In our medical school, we developed a brief homeopathic pathogenetic experimentation course to be added as curricular content and a didactic method in homeopathic disciplines to add practical experience to the theoretical approach of homeopathic presuppositions. In accordance with the premises laid out by Hahnemann, the father of homeopathy, brief pathogenetic experimentation was offered on a voluntary basis for students who were free of chronic diseases and who had not regularly used medication in the last 3 months. The clinical test, either crossed or sequential (randomized and blind), was used as a study model. Single weekly doses of a homeopathic medicine of 30 cH or placebo were taken by participants during 4 weeks after which crossover of the experimented substances took place for another 4 weeks. Polycrest medicines were used so that symptoms developed by the participants could be compared to those described in Homeopathic Materia Medica. Thirty-three of the 50 students who studied homeopathy as an elective discipline over the last 4 years at the School of Medicine of the University of S&atilde;o Paulo (FMUSP) participated. Participants described symptoms according to specific methodology including many comments with peculiar characteristics and notable idiosyncrasies. All these students endorsed the course because it contributed to their understanding of how dynamized substances produced symptoms in healthy participants as well as the cure of symptoms according to the casual similitude principle. Brief homeopathic pathogenetic experimentation proved to be an effective method to observe the idiosyncratic manifestations of human individuality based on qualitative methodology, thus building a basis of understanding of homeopathy.</p>
]]></description>
<dc:creator><![CDATA[Teixeira, M. Z.]]></dc:creator>
<dc:date>Wed, 05 Aug 2009 06:45:29 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem128</dc:identifier>
<dc:title><![CDATA[Brief Homeopathic Pathogenetic Experimentation: A Unique Educational Tool in Brazil]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>414</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>407</prism:startingPage>
<prism:section>Education</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/3/415?rss=1">
<title><![CDATA[Summary of the American College for Advancement in Medicine November 2007 Conference on Integrative Medicine: Advancing Science and Clinical Practice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/3/415?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Speight, N., Hynote, E. D.]]></dc:creator>
<dc:date>Wed, 05 Aug 2009 06:45:29 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen020</dc:identifier>
<dc:title><![CDATA[Summary of the American College for Advancement in Medicine November 2007 Conference on Integrative Medicine: Advancing Science and Clinical Practice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>420</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>415</prism:startingPage>
<prism:section>Meeting Report</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/129?rss=1">
<title><![CDATA[eCAM: Integrative Genomics and Fecundity]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/129?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Cooper, E. L.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:04 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep046</dc:identifier>
<dc:title><![CDATA[eCAM: Integrative Genomics and Fecundity]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>131</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>129</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/133?rss=1">
<title><![CDATA[Static Magnetic Field Therapy: A Critical Review of Treatment Parameters]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/133?rss=1</link>
<description><![CDATA[
<p>Static magnetic field (SMF) therapy, applied via a permanent magnet attached to the skin, is used by people worldwide for self-care. Despite a lack of established SMF dosage and treatment regimens, multiple studies are conducted to evaluate SMF therapy effectiveness. Our objectives in conducting this review are to:(i) summarize SMF research conducted in humans; (ii) critically evaluate reporting quality of SMF dosages and treatment parameters and (iii) propose a set of criteria for reporting SMF treatment parameters in future clinical trials. We searched 27 electronic databases and reference lists. Only English language human studies were included. Excluded were studies of electromagnetic fields, transcranial magnetic stimulation, magnets placed on acupuncture points, animal studies, abstracts, posters and editorials. Data were extracted on clinical indication, study design and 10 essential SMF parameters. Three reviewers assessed quality of reporting and calculated a quality assessment score for each of the 10 treatment parameters. Fifty-six studies were reviewed, 42 conducted in patient populations and 14 in healthy volunteers. The SMF treatment parameters most often and most completely described were site of application, magnet support device and frequency and duration of application. Least often and least completely described were characteristics of the SMF: magnet dimensions, measured field strength and estimated distance of the magnet from the target tissue. Thirty-four (61%) of studies failed to provide enough detail about SMF dosage to permit protocol replication by other investigators. Our findings highlight the need to optimize SMF dosing parameters for individual clinical conditions before proceeding to a full-scale clinical trial.</p>
]]></description>
<dc:creator><![CDATA[Colbert, A. P., Wahbeh, H., Harling, N., Connelly, E., Schiffke, H. C., Forsten, C., Gregory, W. L., Markov, M. S., Souder, J. J., Elmer, P., King, V.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:04 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem131</dc:identifier>
<dc:title><![CDATA[Static Magnetic Field Therapy: A Critical Review of Treatment Parameters]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>139</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>133</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/141?rss=1">
<title><![CDATA[Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/141?rss=1</link>
<description><![CDATA[
<p>The objective of this review is to present examples of lead compounds identified from biological material (fungi, plant extracts and agro-industry material) and of possible interest in the field of a pharmacological approach to the therapy of &beta;-thalassemia using molecules able to stimulate production of fetal hemoglobin (HbF) in adults. Concerning the employment of HbF inducers as potential drugs for pharmacological treatment of &beta;-thalassemia, the following conclusions can be reached: (i) this therapeutic approach is reasonable, on the basis of the clinical parameters exhibited by hereditary persistence of fetal hemoglobin patients, (ii) clinical trials (even if still limited) employing HbF inducers were effective in ameliorating the symptoms of &beta;-thalassemia patients, (iii) good correlation of <I>in vivo</I> and <I>in vitro</I> results of HbF synthesis and -globin mRNA accumulation indicates that <I>in vitro</I> testing might be predictive of <I>in vivo</I> responses and (iv) combined use of different inducers might be useful to maximize HbF, both <I>in vitro</I> and <I>in vivo</I>. In this review, we present three examples of HbF inducers from the natural world: (i) angelicin and linear psoralens, contained in plant extracts from <I>Angelica arcangelica</I> and <I>Aegle marmelos</I>, (ii) resveratrol, a polyphenol found in grapes and several plant extracts and (iii) rapamycin, isolated from <I>Streptomyces hygroscopicus</I>.</p>
]]></description>
<dc:creator><![CDATA[Bianchi, N., Zuccato, C., Lampronti, I., Borgatti, M., Gambari, R.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:04 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem139</dc:identifier>
<dc:title><![CDATA[Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>151</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>141</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/153?rss=1">
<title><![CDATA[Ten Years Evidence-based High-Tech Acupuncture--A Short Review of Peripherally Measured Effects]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/153?rss=1</link>
<description><![CDATA[
<p>Since 1997, the Research Unit of Biomedical Engineering in Anesthesia and Intensive Care Medicine of Graz Medical University has been dealing with the demystification of acupuncture and examining, using non-invasive methods, how different stimulation modalities (manual needle acupuncture, laserneedle acupuncture and electro acupuncture) affect peripheral and central functions. Laser is also an important instrument for acupuncture. One only needs to mention the treatment of children or of patients with needle phobia. The laserneedle acupuncture, which was examined scientifically for the first time in Graz, represents a new painless acupuncture method for which up to ten laserneedles are glued to the skin, but not stuck into it. This first part of the short review article summarizes some of the peripherally measured effects of acupuncture obtained at the Medical University of Graz within the last 10 years.</p>
]]></description>
<dc:creator><![CDATA[Litscher, G.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:04 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem145</dc:identifier>
<dc:title><![CDATA[Ten Years Evidence-based High-Tech Acupuncture--A Short Review of Peripherally Measured Effects]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>158</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>153</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/159?rss=1">
<title><![CDATA[Humor and Laughter May Influence Health IV. Humor and Immune Function]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/159?rss=1</link>
<description><![CDATA[
<p>This is the final article in a four part series reviewing the influence of humor and laughter on physiological and psychological well-being. This final article reviews the evidence for the effect of sense of humor, exposure to a humor stimulus and laughter on various immune system components, with a focus on the effects of laughter on natural killer cell cytotoxicity.</p>
]]></description>
<dc:creator><![CDATA[Bennett, M. P., Lengacher, C.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem149</dc:identifier>
<dc:title><![CDATA[Humor and Laughter May Influence Health IV. Humor and Immune Function]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>164</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>159</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/165?rss=1">
<title><![CDATA[Medical Honey for Wound Care--Still the 'Latest Resort'?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/165?rss=1</link>
<description><![CDATA[
<p>While the ancient Egyptians and Greeks used honey for wound care, and a broad spectrum of wounds are treated all over the world with natural unprocessed honeys from different sources, Medihoney<SUP><SMALL><SMALL>TM</SMALL></SMALL></SUP> has been one of the first medically certified honeys licensed as a medical product for professional wound care in Europe and Australia. Our experience with medical honey in wound care refers only to this product. In this review, we put our clinical experience into a broader perspective to comment on the use of medical honey in wound care. More prospective randomized studies on a wider range of types of wounds are needed to confirm the safety and efficacy of medical honey in wound care. Nonetheless, the current evidence confirming the antibacterial properties and additional beneficial effects of medical honey on wound healing should encourage other wound care professionals to use CE-certified honey dressings with standardized antibacterial activity, such as Medihoney<SUP><SMALL><SMALL>TM</SMALL></SMALL></SUP> products, as an alternative treatment approach in wounds of different natures.</p>
]]></description>
<dc:creator><![CDATA[Simon, A., Traynor, K., Santos, K., Blaser, G., Bode, U., Molan, P.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem175</dc:identifier>
<dc:title><![CDATA[Medical Honey for Wound Care--Still the 'Latest Resort'?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>173</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>165</prism:startingPage>
<prism:section>Commentaries</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/175?rss=1">
<title><![CDATA[Philosophy, Psychology, Physics and Practice of Ki]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/175?rss=1</link>
<description><![CDATA[
<p><I>Ki</I> (in Japanese) or <I>Qi</I> (in Chinese) is the key concept in Eastern medicine, Eastern philosophy, as well as in martial arts. We explain the philosophical and psychological background of <I>Ki</I>. We emphasize that the unique aspects of Eastern philosophy are &lsquo;non-linearity&rsquo; and &lsquo;holistic&rsquo; approach. We then present physics aspect of <I>Ki</I>. Our experiments demonstrated that a &lsquo;<I>Ki</I>-beam&rsquo; carries &lsquo;entropy&rsquo; (or information), which is different from &lsquo;energy&rsquo;. We introduce our experience of having taught <I>Ki</I> to 37 beginners in the United States through the Nishino Breathing Method. If beginners had martial arts training or a strong background in music or dance, about half of them could sense <I>Ki</I> within 10 weeks (1 h class per week) of practice.</p>
]]></description>
<dc:creator><![CDATA[Ohnishi, S. T., Ohnishi, T.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen005</dc:identifier>
<dc:title><![CDATA[Philosophy, Psychology, Physics and Practice of Ki]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>183</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>175</prism:startingPage>
<prism:section>Commentaries</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/185?rss=1">
<title><![CDATA[Acupuncture: What Underlies Needle Administration?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/185?rss=1</link>
<description><![CDATA[
<p>Acupuncture is an ancient Chinese therapy with its mode of action unclear and efficacy inconclusive. A lack of attention given to the role of psychosocial context presented in clinical provision of acupuncture may mainly account for the current dilemma in acupuncture research. This psychosocial context induces various cognitive and affective processes in the patient while receiving this treatment. On the basis of the analysis of these psychological factors involved in clinical provision of acupuncture and in light of prior studies on the placebo effect, the author hypothesizes that acupuncture works through potentiation and modulation of a highly organized and somatotopic network of endogenous opioids that links expectation, attention and body schema. This hypothesis, which focuses on the contextual factors involved in clinical provision of acupuncture, has immediate clinical and experimental implications and will take the acupuncture debate much further forward.</p>
]]></description>
<dc:creator><![CDATA[Liu, T.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen002</dc:identifier>
<dc:title><![CDATA[Acupuncture: What Underlies Needle Administration?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>193</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>185</prism:startingPage>
<prism:section>Hypothesis</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/195?rss=1">
<title><![CDATA[Hepatoprotective Activity of Licorice Water Extract against Cadmium-induced Toxicity in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/195?rss=1</link>
<description><![CDATA[
<p>Licorice is commonly used as a cure for digestive disorders and as a detoxification agent in East Asia. This study investigated the protective effect of licorice water extract against cadmium (CdCl<SUB>2</SUB>, Cd)-induced liver toxicity in rats. To induce acute toxicity, Cd (4 mg/kg body weight) was dissolved in normal saline and intravenously (i.v.) injected into rats. The rats then received either a vehicle or licorice water extract (50, 100 mg/kg/day) for 3 days, and were subsequently exposed to a single injection of Cd 24 h after the last licorice/vehicle treatment. Alanine aminotransferase (ALT), aspartate aminotransferase (AST) and lactate dehydrogenase (LDH) were significantly increased by Cd treatment. In contrast, pretreatment with licorice reduced ALT, AST and LDH. In histopathological analysis, licorice decreased the central necrosis around central veins, the peripheral hemorrhage around portal triads, the percentage of degenerative hepatic regions (%/mm<sup>2</sup> hepatic parenchyma) and the number of degenerative hepatic cells (<I>N</I>/100 hepatic cells). Licorice also inhibited the increment of Bad (a BH3 domain-containing protein) translocation by Cd in liver cells. These results demonstrate that licorice could have a hepatoprotective effect by inhibiting the translocation of Bad to the mitochondria in Cd-intoxificated rats.</p>
]]></description>
<dc:creator><![CDATA[Lee, J. R., Park, S. J., Lee, H.-S., Jee, S. Y., Seo, J., Kwon, Y. K., Kwon, T. K., Kim, S. C.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem078</dc:identifier>
<dc:title><![CDATA[Hepatoprotective Activity of Licorice Water Extract against Cadmium-induced Toxicity in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>201</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>195</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/203?rss=1">
<title><![CDATA[Enhancement of Amygdaloid Neuronal Dendritic Arborization by Fresh Leaf Juice of Centella asiatica (Linn) During Growth Spurt Period in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/203?rss=1</link>
<description><![CDATA[
<p>C<I>entella asiatica</I> (CeA) is a creeping herb, growing in moist places in India and other Asian Countries. Ayurvedic system of medicine, an alternate system of medicine in India, uses leaves of CeA for memory enhancement. Here, we have investigated the role of CeA fresh leaf juice treatment during growth spurt period of rats on dendritic morphology of amygdaloid neurons, one of the regions concerned with learning and memory. The present study was conducted on neonatal rat pups. The rat pups (7-days-old) were fed with 2, 4 and 6 ml/kg body of fresh leaf juice of CeA for 2, 4 and 6 weeks. After the treatment period, the rats were killed, brains removed and amygdaloid neurons impregnated with Silver nitrate (Golgi staining). Amygdaloid neurons were traced using camera lucida and dendritic branching points (a measure of dendritic arborization) and intersections (a measure dendritic length) quantified. These data were compared with those of age-matched control rats. The results showed a significant increase in dendritic length (intersections) and dendritic branching points along the length of dendrites of the amygdaloid neurons of rats treated with 4 and 6 ml/kg body weight/day of CeA for longer periods of time (i.e. 4 and 6 weeks). We conclude that constituents/active principles present in CeA fresh leaf juice has neuronal dendritic growth stimulating property; hence it can be used for enhancing neuronal dendrites in stress and other neurodegenerative and memory disorders.</p>
]]></description>
<dc:creator><![CDATA[Mohandas Rao, K. G., Muddanna Rao, S., Gurumadhva Rao, S.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem079</dc:identifier>
<dc:title><![CDATA[Enhancement of Amygdaloid Neuronal Dendritic Arborization by Fresh Leaf Juice of Centella asiatica (Linn) During Growth Spurt Period in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>210</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>203</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/211?rss=1">
<title><![CDATA[Tibetan Medicated-Bath Therapy may Improve Adjuvant Arthritis in Rat]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/211?rss=1</link>
<description><![CDATA[
<p>Tibetan medicated-bath therapy has been applied to patients with rheumatoid arthritis for centuries. However, the detailed action mechanism of Tibetan medicated-bath therapy on the morphology and function of joints remains unknown. We designed our investigation to evaluate the efficacy of Tibetan medicated-bath therapy on adjuvant arthritis (AA) of rats in comparison with water-bath and dexamethasone administration. AA was induced by intradermal injection of <I>Mycobacterium butyricum</I> suspended in sterile mineral oil. The control animals were similarly injected with sterile vehicle. Eight days after injection, rats were treated with fresh-water bath, Tibetan medicated-bath (40&deg;C, 15 min) or intramuscular injection with dexamethasone for 21 consecutive days after which we evaluated the severity of arthritis visually and microscopically and measured serum interleukin (IL)-6 and tumor necrosis factor (TNF)- levels. While arthritis did not significantly change after water-bath treatment, the Tibetan medicated-bath and dexamethasone groups showed diminished joint swelling and alleviation of, inflammatory cell infiltration and the destruction of bone and cartilage. Serum IL-6 and TNF- levels significantly decreased. Our results demonstrated that Tibetan medicated-bath therapy exerted a reliable effect on rat adjuvant arthritis, which may be involved in the inflammatory cytokines, IL-6 and TNF-. Our data provide evidence for clinical use of Tibetan-medicated bath therapy for arthritis patients.</p>
]]></description>
<dc:creator><![CDATA[Chen, H., Shoumura, S., Emura, S., Isono, H.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem083</dc:identifier>
<dc:title><![CDATA[Tibetan Medicated-Bath Therapy may Improve Adjuvant Arthritis in Rat]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>217</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>211</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/219?rss=1">
<title><![CDATA[Asparagus Root Regulates Cholesterol Metabolism and Improves Antioxidant Status in Hypercholesteremic Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/219?rss=1</link>
<description><![CDATA[
<p>Hyperlipidemia/hypercholesteremia are major risk factors for atherosclerosis and cardiovascular diseases. Root of <I>Asparagus racemosus</I> (AR) is widely used in Ayurvedic system of medicine in India and is known for its steroidal saponin content. This study was designed to investigate the hypocholesteremic and antioxidant potential of AR root in both normo- and hypercholesteremic animals. Normal and hypercholesteremic male albino rats were administered with root powder of AR (5 and 10 g% dose levels) along with normal and hypercholesteremic diets, respectively, for a duration of 4 weeks. Plasma and hepatic lipid profiles, fecal sterol, bile acid excretion and hepatic antioxidant activity were assessed. Inclusion of AR root powder in diet, resulted in a dose-dependant reduction in plasma and hepatic lipid profiles, increased fecal excretion of cholesterol, neutral sterol and bile acid along with increases in hepatic HMG-CoA reductase activity and bile acid content in hypercholesteremic rats. Further, AR root also improved the hepatic antioxidant status (catalase, SOD and ascorbic acid levels). No significant changes in lipid and antioxidant profiles occurred in the normocholesteremic rats administered with AR root powder. AR root appeared to be useful as a dietary supplement that offers a protection against hyperlipidemia/hypercholesteremia in hypercholesteremic animals. The results of the present study indicate that the potent therapeutic phyto-components present in AR root i.e. phytosterols, saponins, polyphenols, flavonoids and ascorbic acid, could be responsible for increased bile acid production, elimination of excess cholesterol and elevation of hepatic antioxidant status in hypercholesteremic conditions.</p>
]]></description>
<dc:creator><![CDATA[Visavadiya, N. P., Narasimhacharya, A. V. R. L.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem091</dc:identifier>
<dc:title><![CDATA[Asparagus Root Regulates Cholesterol Metabolism and Improves Antioxidant Status in Hypercholesteremic Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>226</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>219</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/227?rss=1">
<title><![CDATA[Evaluation of Antioxidant Properties of Phaulopsis fascisepala C.B.Cl. (Acanthaceae)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/227?rss=1</link>
<description><![CDATA[
<p>The antioxidant activities of crude extract of <I>Phaulopsis fascisepala</I> leaf were evaluated and compared with -tocopherol and BHT as synthetic antioxidants and ascorbic acid as natural-based antioxidant. <I>In vitro</I>, we studied its antioxidative activities, radical-scavenging effects, Fe<sup>2+</sup>-chelating ability and reducing power. The total phenolic content was determined and expressed in gallic acid equivalent. The extract showed variable activities in all of these <I>in vitro</I> tests. The antioxidant effect of <I>P. fascisepala</I> was strongly dose dependent, increased with increasing leaf extract dose and then leveled off with further increase in extract dose. Compared to other antioxidants used in the study, -Tocopherol, ascorbic acid and BHT, <I>P. fascisepala</I> leaf extract showed less scavenging effect on ,,-diphenyl-&beta;-picrylhydrazyl (DPPH) radical and less reducing power on Fe<sup>3+</sup>/ferricyanide complex but better Fe<sup>2+</sup>-chelating ability. These results revealed the <I>in vitro</I> antioxidant activity of <I>P</I>. <I>fascisepala.</I> Further investigations are necessary to verify these activities <I>in vivo</I>.</p>
]]></description>
<dc:creator><![CDATA[Adesegun, S. A., Fajana, A., Orabueze, C. I., Coker, H. A. B.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem098</dc:identifier>
<dc:title><![CDATA[Evaluation of Antioxidant Properties of Phaulopsis fascisepala C.B.Cl. (Acanthaceae)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>231</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>227</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/233?rss=1">
<title><![CDATA[Regulation of Caspase-3 and Bcl-2 Expression in Dalton's Lymphoma Ascites Cells by Abrin]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/233?rss=1</link>
<description><![CDATA[
<p>The role of abrin, a toxic lectin isolated from seeds of <I>Abrus precatorius</I> Linn in inducing apoptosis in murine Dalton's Lymphoma Ascites (DLA) cells was evaluated. Abrin when incubated at the concentration of 10 ng per million DLA cells could bring about cell death as typical morphological changes with apoptosis. However, necrotic cell death dominated when a higher dose of abrin was used. DNA samples, isolated from DLA cells treated with abrin showed fragmentation. Abrin brought about induction of apoptosis by stimulating the expression of pro-apoptotic Caspase-3, at the same time blocking the expression of Bcl-2, which is an anti apoptotic gene. However, the expression of tumor suppressor gene p53 has not been observed in control and abrin-treated DLA cells. Results suggested that abrin effectively induced apoptotic changes in the tumor cells that led to cellular death.</p>
]]></description>
<dc:creator><![CDATA[Ramnath, V., Rekha, P. S., Kuttan, G., Kuttan, R.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem099</dc:identifier>
<dc:title><![CDATA[Regulation of Caspase-3 and Bcl-2 Expression in Dalton's Lymphoma Ascites Cells by Abrin]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>238</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>233</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/239?rss=1">
<title><![CDATA[Pain Controlling and Cytokine-regulating Effects of Lyprinol, a Lipid Extract of Perna Canaliculus, in a Rat Adjuvant-induced Arthritis Model]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/239?rss=1</link>
<description><![CDATA[
<p>Using an adjuvant-induced arthritis rat model, we investigated the effects of a lipid extract of <I>Perna canaliculus</I> (Lyprinol&reg;) on pain. Radiological examinations, as well as levels of pro- and anti-inflammatory (AI) cytokines, were measured aiming to provide independent objective data to the pain controlling investigation. We confirmed the ability of Lyprinol&reg; to control pain at the initial phase of its administration; with similar efficacy to that observed with Naproxen. The pain scores slowly increased again in the group of rats treated with Lyprinol&reg; after day 9&ndash;14. The Naproxen-treated rats remained pain-free while treated. Both Naproxen and Lyprinol&reg; decreased the levels of the pro-inflammatory cytokines TNF- and IFN-, and increased that of IL-10. Extra-virgin olive oil was ineffective on cytokine secretion. Rats treated with Lyprinol&reg; were apparently cured after 1 year. This study confirms the AI efficacy of this lipid extract of <I>P. canaliculus</I>, its initial analgesic effect, its perfect tolerance and its long-term healing properties.</p>
]]></description>
<dc:creator><![CDATA[Lee, C.-H., Lum, J. H.-K., Ng, C. K.-C., McKay, J., Butt, Y. K.-C., Wong, M.-S., Lo, S. C.-L.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem100</dc:identifier>
<dc:title><![CDATA[Pain Controlling and Cytokine-regulating Effects of Lyprinol, a Lipid Extract of Perna Canaliculus, in a Rat Adjuvant-induced Arthritis Model]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>245</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>239</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/247?rss=1">
<title><![CDATA[Oral Administration of Ren-Shen-Yang-Rong-Tang 'Ninjin'yoeito' Protects Against Hematotoxicity and Induces Immature Erythroid Progenitor Cells in 5-Fluorouracil-induced Anemia]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/247?rss=1</link>
<description><![CDATA[
<p>The purpose of this study was to investigate the efficacy of four different Japanese and Chinese herbal prescriptions, Ren-Shen-Yang-Rong-Tang (Ninjin&rsquo;yoeito, NYT), Chai-Hu-Gui-Zhi-Gan-Jiang-Tang (Saikokeishikankyoto, SKKT), Si-Jun-Zi-Tang (Shikunshito, SKT) and Si-Wu-Tang (Shimotsuto, SMT), which are traditionally used for anemia and fatigue, against hematotoxicity in mice treated with 5-fluorouracil (5-FU). NYT 1&ndash;100 mg kg<sup>&ndash;1</sup> day<sup>&ndash;1</sup> injected orally for 7 consecutive days before and after 5-FU injection significantly suppressed reductions in red blood cell, white blood cell and platelet counts in peripheral blood, and accelerated their recovery. Administration of SKKT also produced a slight but significant improvement in 5-FU-induced erythrocytopenia, whereas SMT and SKT could not prevent anemia. Oral injection of NYT also inhibited 5-FU-induced decreases in peripheral reticulocyte and bone marrow cell counts on day 10, and markedly hastened their recovery on day 20, in a dose-dependent manner. Erythroid progenitor colonies, such as colony forming units-erythroid and burst forming units-erythroid, formed by marrow cells from mice treated with 5-FU were significantly increased by oral administration of NYT. These findings suggest that NYT has the potential to protect against hematotoxicity, and also has hematopoietic activity, through stimulation of immature erythroid progenitor cell differentiation.</p>
]]></description>
<dc:creator><![CDATA[Takano, F., Ohta, Y., Tanaka, T., Sasaki, K., Kobayashi, K., Takahashi, T., Yahagi, N., Yoshizaki, F., Fushiya, S., Ohta, T.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem080</dc:identifier>
<dc:title><![CDATA[Oral Administration of Ren-Shen-Yang-Rong-Tang 'Ninjin'yoeito' Protects Against Hematotoxicity and Induces Immature Erythroid Progenitor Cells in 5-Fluorouracil-induced Anemia]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>256</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>247</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/257?rss=1">
<title><![CDATA[Dynamized Preparations in Cell Culture]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/257?rss=1</link>
<description><![CDATA[
<p>Although reports on the efficacy of homeopathic medicines in animal models are limited, there are even fewer reports on the <I>in vitro</I> action of these dynamized preparations. We have evaluated the cytotoxic activity of 30C and 200C potencies of ten dynamized medicines against Dalton's Lymphoma Ascites, Ehrlich's Ascites Carcinoma, lung fibroblast (L929) and Chinese Hamster Ovary (CHO) cell lines and compared activity with their mother tinctures during short-term and long-term cell culture. The effect of dynamized medicines to induce apoptosis was also evaluated and we studied how dynamized medicines affected genes expressed during apoptosis. Mother tinctures as well as some dynamized medicines showed significant cytotoxicity to cells during short and long-term incubation. Potentiated alcohol control did not produce any cytotoxicity at concentrations studied. The dynamized medicines were found to inhibit CHO cell colony formation and thymidine uptake in L929 cells and those of <I>Thuja</I>, <I>Hydrastis</I> and <I>Carcinosinum</I> were found to induce apoptosis in DLA cells. Moreover, dynamized Carcinosinum was found to induce the expression of p53 while dynamized Thuja produced characteristic laddering pattern in agarose gel electrophoresis of DNA. These results indicate that dynamized medicines possess cytotoxic as well as apoptosis-inducing properties.</p>
]]></description>
<dc:creator><![CDATA[Sunila, E. S., Kuttan, R., Preethi, K. C., Kuttan, G.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem082</dc:identifier>
<dc:title><![CDATA[Dynamized Preparations in Cell Culture]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>263</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>257</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/265?rss=1">
<title><![CDATA[Qigong Ameliorates Symptoms of Chronic Fatigue: A Pilot Uncontrolled Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/265?rss=1</link>
<description><![CDATA[
<p>Traditional Chinese Medicine practitioners consider that chronic fatigue reflects a disharmony and depletion in the supply of <I>qi</I> in the body. Qigong is one of the traditional complementary interventions used to strengthen <I>qi</I> through self-practice, and to manage the state of <I>qi</I> to prevent and cure disease. The aim of this study is to assess whether qigong could be used to manage the symptoms of chronic fatigue. Eighteen Caucasian, British female participants were recruited, taught a qigong routine during weekly classes over 6 months, and asked to practice it daily for 15 min. Participants completed the core set of the RAND Medical Outcomes Study questionnaire (RAND MOS) and a sleep diary during the 2-week baseline control period, and at 3 and 6 months following the start of the trial. The qigong intervention resulted in significant changes in sleep rate score and in the following subscales of the RAND MOS: SF36 Vitality, Sleep Problems, Social Activity, Social Activity Limitation due to Health, Health Distress, Mental Health Index and Psychological Well-being. Qigong seems to improve factors related to chronic fatigue such as sleep, pain, mental attitude and general mobility after 3 and 6 months. Qigong's positive effects indicate that it represents a potentially safe method of treatment for chronic fatigued patients. However, we cannot completely discount the possible influence of placebo effects, and more objective clinical measures are needed to reproduce our findings with long-term follow-up in a randomized, controlled study involving a larger number of subjects.</p>
]]></description>
<dc:creator><![CDATA[Craske, N. J. M., Turner, W., Zammit-Maempe, J., Lee, M. S.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem088</dc:identifier>
<dc:title><![CDATA[Qigong Ameliorates Symptoms of Chronic Fatigue: A Pilot Uncontrolled Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>270</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>265</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/271?rss=1">
<title><![CDATA[Laughter, Humor and Pain Perception in Children: A Pilot Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/271?rss=1</link>
<description><![CDATA[
<p>Although there are many clinical programs designed to bring humor into pediatric hospitals, there has been very little research with children or adolescents concerning the specific utility of humor for children undergoing stressful or painful procedures. Rx Laughter<SUP><SMALL><SMALL>TM</SMALL></SMALL></SUP>, a non-profit organization interested in the use of humor for healing, collaborated with UCLA to collect preliminary data on a sample of 18 children aged 7&ndash;16 years. Participants watched humorous video-tapes before, during and after a standardized pain task that involved placing a hand in cold water. Pain appraisal (ratings of pain severity) and pain tolerance (submersion time) were recorded and examined in relation to humor indicators (number of laughs/smiles during each video and child ratings of how funny the video was). Whereas humor indicators were not significantly associated with pain appraisal or tolerance, the group demonstrated significantly greater pain tolerance while viewing funny videos than when viewing the videos immediately before or after the cold-water task. The results suggest that humorous distraction is useful to help children and adolescents tolerate painful procedures. Further study is indicated to explore the specific mechanism of this benefit.</p>
]]></description>
<dc:creator><![CDATA[Stuber, M., Hilber, S. D., Mintzer, L. L., Castaneda, M., Glover, D., Zeltzer, L.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem097</dc:identifier>
<dc:title><![CDATA[Laughter, Humor and Pain Perception in Children: A Pilot Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>276</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>271</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/2/277?rss=1">
<title><![CDATA[Aspects of Sino-Japan Complementary and Alternative Medicine and Development on the Traditional Uighur Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/2/277?rss=1</link>
<description><![CDATA[
<p>Two consecutive conferences on &lsquo;Sino-Japan Complementary and Alternative Medicine and Development on the Traditional Uighur Medicine&rsquo; were held in Xinjiang Medical University on July 3 and Kanazawa Medical University on October 6, 2007. The Vice president Halmurat Upur presided over the meeting and gave congratulatory address on holding of the conference. In order to understand mutually and discuss the possibility of the Uighur Medicine as CAM and the situation of medicine in the global sense, specialist scholars of Traditional Uighur Medicine and postgraduates attended this conference. In the meeting of the CAM, the achievements on the research of Traditional Uighur Medicine were exchanged and warmly discussed. Presentations were made in the consecutive conference.</p>
]]></description>
<dc:creator><![CDATA[Yusup, A., Yamaguchi, N.]]></dc:creator>
<dc:date>Tue, 26 May 2009 02:49:05 PDT</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen012</dc:identifier>
<dc:title><![CDATA[Aspects of Sino-Japan Complementary and Alternative Medicine and Development on the Traditional Uighur Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>278</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>277</prism:startingPage>
<prism:section>Meeting Report</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/1?rss=1">
<title><![CDATA[eCAM: Clinical Analyses and Increasing Visibility]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Cooper, E. L.]]></dc:creator>
<dc:date>Tue, 17 Feb 2009 07:15:24 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nep008</dc:identifier>
<dc:title><![CDATA[eCAM: Clinical Analyses and Increasing Visibility]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>2</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>1</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/3?rss=1">
<title><![CDATA[Dysautonomia, A Heuristic Approach to a Revised Model for Etiology of Disease]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/3?rss=1</link>
<description><![CDATA[
<p>Dysautonomia refers to a disease where the autonomic nervous system is dysfunctional. This may be a central control mechanism, as in genetically determined familial dysautonomia (Riley-Day Syndrome), or peripherally in the distribution of the sympathetic and parasympathetic systems. There are multiple reports of a number of different diseases associated with dysautonomia. The etiology of this association has never been explained. There are also multiple publications on dysautonomia associated with specific non-caloric nutritional deficiencies. Beriberi is the prototype of autonomic dysfunction. It is the best known nutritional deficiency disease caused by an imbalance between ingested calories and the vitamins required for their oxidation, particularly thiamin. Long thought to be abolished in modern medical thinking, there are occasional isolated reports of the full-blown disease in developed Western cultures.</p>
<p>Apart from genetically and epigenetically determined disease, evidence is presented that marginal high calorie malnutrition, particularly with reference to simple carbohydrates, is responsible for widespread dysautonomia. The brain and heart are the organs that have a fast rate of oxidative metabolism and are affected early by any mechanism that reduces oxidative efficiency. It is hypothesized that this results in a chaotic state of the hypothalamic/autonomic/endocrine axis. Due to the lack of adequate automatic controls, this may be responsible in some cases for breakdown of organ systems through long-standing energy deficiency, thus leading eventually to organic disease.</p>
]]></description>
<dc:creator><![CDATA[Lonsdale, D.]]></dc:creator>
<dc:date>Tue, 17 Feb 2009 07:15:24 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem064</dc:identifier>
<dc:title><![CDATA[Dysautonomia, A Heuristic Approach to a Revised Model for Etiology of Disease]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>10</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>3</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/11?rss=1">
<title><![CDATA[Analgesic Action of Acupuncture and Moxibustion: A Review of Unique Approaches in Japan]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/11?rss=1</link>
<description><![CDATA[
<p>The mechanism of acupuncture analgesia (AA) is one of the most widely researched topics in complementary and alternative medicine (CAM) based on modern medical methodology. Endogenous opioid-mediated mechanisms of acupuncture have been well established since the 1970s. In this review, we have covered the progress of AA research by Japanese investigators. In particular, we have reviewed the physiological basis of analgesic effects induced by acupuncture and moxibustion, including the actions of endogenous opioid and diffuse noxious inhibitory controls (DNICs), and the afferent fibers participating in acupuncture and moxibustion stimuli are discussed.</p>
]]></description>
<dc:creator><![CDATA[Okada, K., Kawakita, K.]]></dc:creator>
<dc:date>Tue, 17 Feb 2009 07:15:24 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem090</dc:identifier>
<dc:title><![CDATA[Analgesic Action of Acupuncture and Moxibustion: A Review of Unique Approaches in Japan]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>17</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>11</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/19?rss=1">
<title><![CDATA[Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/19?rss=1</link>
<description><![CDATA[
<p>In Europe many cancer patients use complementary therapies, particularly mistletoe. Only a few controlled clinical trials have been performed with the mistletoe preparation Iscador as a complementary treatment for cancer, many of them with medium to low quality due to methodological shortcomings. Reasons for some quality concerns, particularly discontinuation of treatment and/or participation and premature termination are analyzed. Analysis is based on controlled clinical trials dealing with Iscador. Data stem from the archive of published and ongoing research of the &laquo;Verein f&uuml;r Krebsforschung&raquo; (Society for Cancer Research) in Arlesheim, Switzerland. Controlled clinical studies with cancer patients that were started after 01.01.1990 or were not completed by then have been evaluated. Fifty-six controlled studies are documented, 24 of them randomized and 32 non-randomized. Nine of the randomized studies were done by matched-pair design, the others by conventional parallel group design; six of the last were terminated prematurely primarily for slow recruitment due to patient preferences and compliance of physicians. Patient and physician preference seem to be important factors limiting recruitment for randomized trials and hence implementation. This adds to the overall unwillingness of participation by patients with serious diseases. A well-balanced mix of designs using different research methods and outcomes is suggested combined with analyses, in countries where mistletoe therapy in general or Iscador in particular is unknown or not available.</p>
]]></description>
<dc:creator><![CDATA[Ziegler, R.]]></dc:creator>
<dc:date>Tue, 17 Feb 2009 07:15:24 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem121</dc:identifier>
<dc:title><![CDATA[Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>30</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>19</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/31?rss=1">
<title><![CDATA[Prospective Tests on Biological Models of Acupuncture]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/31?rss=1</link>
<description><![CDATA[
<p>The biological effects of acupuncture include the regulation of a variety of neurohumoral factors and growth control factors. In science, models or hypotheses with confirmed predictions are considered more convincing than models solely based on retrospective explanations. Literature review showed that two biological models of acupuncture have been prospectively tested with independently confirmed predictions: The neurophysiology model on the long-term effects of acupuncture emphasizes the trophic and anti-inflammatory effects of acupuncture. Its prediction on the peripheral effect of endorphin in acupuncture has been confirmed. The growth control model encompasses the neurophysiology model and suggests that a macroscopic growth control system originates from a network of organizers in embryogenesis. The activity of the growth control system is important in the formation, maintenance and regulation of all the physiological systems. Several phenomena of acupuncture such as the distribution of auricular acupuncture points, the long-term effects of acupuncture and the effect of multimodal non-specific stimulation at acupuncture points are consistent with the growth control model. The following predictions of the growth control model have been independently confirmed by research results in both acupuncture and conventional biomedical sciences: (i) Acupuncture has extensive growth control effects. (ii) Singular point and separatrix exist in morphogenesis. (iii) Organizers have high electric conductance, high current density and high density of gap junctions. (iv) A high density of gap junctions is distributed as separatrices or boundaries at body surface after early embryogenesis. (v) Many acupuncture points are located at transition points or boundaries between different body domains or muscles, coinciding with the connective tissue planes. (vi) Some morphogens and organizers continue to function after embryogenesis. Current acupuncture research suggests a convergence of the neurophysiology model, the connective tissue model and the growth control model. The growth control model of acupuncture set the first example of a biological model in integrative medicine with significant prediction power.</p>
]]></description>
<dc:creator><![CDATA[Shang, C.]]></dc:creator>
<dc:date>Tue, 17 Feb 2009 07:15:24 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem122</dc:identifier>
<dc:title><![CDATA[Prospective Tests on Biological Models of Acupuncture]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>39</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>31</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/41?rss=1">
<title><![CDATA[Randomized Clinical Trials on Acupuncture in Korean Literature: A Systematic Review]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/41?rss=1</link>
<description><![CDATA[
<p>The aim of this systematic review was to summarize randomized clinical trials (RCTs) assessing the effectiveness of acupuncture as published in Korean literature. Systematic searches were conducted on eight Korean medical databases. Manual searches were also conducted through eight major Korean medical journals. The methodological quality was assessed using a Jadad score. Studies evaluating needle acupuncture or auricular acupuncture (AA) with or without electrical stimulation were considered if they were sham or placebo-controlled or controlled against a comparative intervention. We also excluded acupuncture as an adjuvant to other treatments and other forms of acupuncture were excluded. Seven hundred and nine possibly relevant studies were identified and 10 RCTs were included. The methodological quality of the trials was generally poor. Manual acupuncture was compared to placebo acupuncture in four studies of patients with chronic low back pain, shoulder pain, premenstrual syndrome and allergic rhinitis. Three studies tested AA (two trials) and electroacupuncture (one trial) against no treatment, while three trials compared acupuncture with other active therapeutic controls. The methodological limitations of the included trials make their contribution to the current clinical evidence of acupuncture somewhat limited. The trial for premenstrual syndrome, shoulder pain and chronic low back pain added a limited contribution among those included RCTs. However, well-designed RCTs of acupuncture with a rigorous methodology are in progress or have been completed in Korea and will contribute to establish or contribute to the current progress of research in this field.</p>
]]></description>
<dc:creator><![CDATA[Kong, J. C., Lee, M. S., Shin, B.-C.]]></dc:creator>
<dc:date>Tue, 17 Feb 2009 07:15:24 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem130</dc:identifier>
<dc:title><![CDATA[Randomized Clinical Trials on Acupuncture in Korean Literature: A Systematic Review]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>48</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>41</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/49?rss=1">
<title><![CDATA[Between-Groups Study Designs Demand Between-Groups Analyses: A Response to Hernandez-Reif, Shor-Posner, Baez, Soto, Mendoza, Castillo, Quintero, Perez, and Zhang]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/49?rss=1</link>
<description><![CDATA[
<p>The most recent massage therapy (MT) study by Hernandez-Reif <I>et al.</I> displays flaws persistent in this area of research that are attributable to MT researchers&rsquo; frequent mistake of using within-group analyses of dependent variables in studies that are purported to be randomized control trials. This practise violates the logic of using randomization to create treatment and control groups, and thereby fails to control for the validity threats of spontaneous remission, placebo effects, and statistical regression. The result is that a clear understanding of what MT can and cannot do is seriously hampered.</p>
]]></description>
<dc:creator><![CDATA[Moyer, C. A.]]></dc:creator>
<dc:date>Tue, 17 Feb 2009 07:15:24 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem164</dc:identifier>
<dc:title><![CDATA[Between-Groups Study Designs Demand Between-Groups Analyses: A Response to Hernandez-Reif, Shor-Posner, Baez, Soto, Mendoza, Castillo, Quintero, Perez, and Zhang]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>50</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>49</prism:startingPage>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/51?rss=1">
<title><![CDATA[Neurochemical Mechanism of Electroacupuncture: Anti-injury Effect on Cerebral Function after Focal Cerebral Ischemia in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/51?rss=1</link>
<description><![CDATA[
<p>We explored the neurochemical mechanism of electroacupuncture's (EA) protective effect on brain function in focal cerebral ischemia rats, using cerebral ischemia/reperfusion rats established by the middle cerebral artery occlusion (MCAO) method. Adult male Sprague&ndash;Dawley rats were randomly divided into four groups: Sham, Sham+EA, MCAO and MCAO+EA. The rats in Sham+EA and MCAO+EA were accepted EA treatment at &lsquo;GV26&rsquo; and &lsquo;GV20&rsquo; acupoints for 30 min. Electric stimulation was produced by a G-6805 generator and neurological deficit scores were recorded. Mitochondria respiratory function and the activities of respiratory enzymes were measured by a computer-aided Clark oxygen electrode system. Results showed that EA treatment might reduce the neurological deficit score, and significantly improve respiratory control ratio (RCR), the index of mitochondrial respiratory function, and increase the activities of succinic dehydrogenase, NADH dehydrogenase and cytochrome C oxidase in the MCAO rats. Results suggest that EA might markedly decrease the neurological deficit score, promote the activities of respiratory enzymes and reduce the generation of reactive oxygen species (ROS), resulting in improvement of respiratory chain function and anti-oxidative capability of brain tissues in the infarct penumbra zone. This be a mechanism of EA's anti-injury effect on brain function in MCAO rats.</p>
]]></description>
<dc:creator><![CDATA[Zhong, S., Li, Z., Huan, L., Chen, B.-Y.]]></dc:creator>
<dc:date>Tue, 17 Feb 2009 07:15:24 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem062</dc:identifier>
<dc:title><![CDATA[Neurochemical Mechanism of Electroacupuncture: Anti-injury Effect on Cerebral Function after Focal Cerebral Ischemia in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>56</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>51</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/57?rss=1">
<title><![CDATA[Screening of Bioactive Compounds from Moutan Cortex and Their Anti-Inflammatory Activities in Rat Synoviocytes]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/57?rss=1</link>
<description><![CDATA[
<p>Moutan Cortex, a widely used traditional Chinese medicine for the treatment of various diseases, is the root bark of <I>Paeonia suffruticosa Andrews</I> (Paeoniaceae). Most of the pharmacological investigations of Moutan Cortex have been addressed to its central nervous system activities, anti-oxidative and sedative actions. Otherwise, there are few reports about the active compounds with anti-inflammatory activity of Moutan Cortex. The aim of the present study was to screen and identify bioactive compounds with anti-inflammatory effect from Moutan Cortex. With the aid of preparative high performance liquid chromatography (HPLC) technique, ethyl acetate and ethanol extract of Moutan Cortex were isolated into twenty-two fractions. Bioactivities of these fractions were evaluated by measuring expression of tumor necrosis factor- (TNF-) in rat synoviocytes subjected to interleukin-1&beta; (IL-1&beta;). Eight compounds were isolated from six active fractions and identified by HPLC/MS<sup>n</sup>. Purified compounds, paeoniflorin, paeonol and pentagalloylglucose resulted in dose-dependent inhibition of TNF- synthesis and IL-6 production in synoviocytes treated with proinflammatory mediator. These results suggested that paeonol, paeoniflorin, glycosides and pentagalloylglucose contribute to the anti-inflammatory effect of Moutan Cortex.</p>
]]></description>
<dc:creator><![CDATA[Wu, M., Gu, Z.]]></dc:creator>
<dc:date>Tue, 17 Feb 2009 07:15:24 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem066</dc:identifier>
<dc:title><![CDATA[Screening of Bioactive Compounds from Moutan Cortex and Their Anti-Inflammatory Activities in Rat Synoviocytes]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>63</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>57</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/65?rss=1">
<title><![CDATA[Amelioration of Carcinogen-Induced Toxicity in Mice by Administration of a Potentized Homeopathic Drug, Natrum Sulphuricum 200]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/65?rss=1</link>
<description><![CDATA[
<p>To examine if a potentized homeopathic drug, Natrum Sulphuricum 200 (Nat Sulph-200) has protective potentials against hepatocarcinogenesis, liver tumors were induced in mice through chronic feeding of <I>P</I>-dimethylaminoazobenzene (p-DAB; initiator of hepatocarcinogenesis) and phenobarbital (PB; promoter). Mice were divided into five sub-groups: fed normal low protein diet (Gr. I, normal control); fed normal low protein plus alcohol-200 (vehicle of the homeopathic remedy) (Gr. II); fed diet mixed with 0.06% p-DAB plus 0.05% PB (Gr. III); fed diet and carcinogens like Gr.III, plus alcohol 200 (positive control for drug fed mice) (Gr. IV) and fed diet and carcinogens like Gr. III, plus Natrum Sulphuiricum-200 (Gr. V; drug fed). Mice were sacrificed at day 7, 15, 30, 60, 90 and day 120 for study of cytogenetical endpoints like chromosome aberrations (CA), micronuclei (MN), mitotic index (MI) and sperm head anomaly (SHA) and biochemical toxicity parameters like aspartate amino transferase (AST), alanine amino transferase (ALT), acid (AcP) and alkaline (AlkP) phosphatases, lipid peroxidation (LPO) and reduced glutathione (GSH) content. Less number of liver tumors were observed in Gr. V (drug fed) mice. Administration of Nat Sulph 200 reduced genomic damage, activities of AcP, AlkP, AST, ALT, LPO and increased GSH content. Therefore, independent replication of the study by others is encouraged.</p>
]]></description>
<dc:creator><![CDATA[Bhattacharjee, N., Pathak, S., Khuda-Bukhsh, A. R.]]></dc:creator>
<dc:date>Tue, 17 Feb 2009 07:15:24 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem067</dc:identifier>
<dc:title><![CDATA[Amelioration of Carcinogen-Induced Toxicity in Mice by Administration of a Potentized Homeopathic Drug, Natrum Sulphuricum 200]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>75</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>65</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/77?rss=1">
<title><![CDATA[Acupuncture on the Blood Flow of Various Organs Measured Simultaneously by Colored Microspheres in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/77?rss=1</link>
<description><![CDATA[
<p>We examined how acupuncture affected the blood flow of muscle, kidney, stomach, small intestine, brain, lung, heart, spleen and liver. Wistar rats anesthetized with urethane (<I>n</I> = 27) were allocated into the control (<I>n</I> = 10), ST-7 (Hsia-Kuan, <I>n</I> = 10) and LI-4 (Hoku, <I>n</I> = 7) groups. To measure organ blood flow, colored microspheres (CMS) were injected through a catheter positioned in the left ventricle and blood samples were drawn from the femoral artery. Yellow CMS (3.6&ndash;4.2 <FONT FACE="arial,helvetica">x</FONT> 10<sup>5</sup>) and blue CMS (6.0&ndash;6.9 <FONT FACE="arial,helvetica">x</FONT> 10<sup>5</sup>) were injected at intervals of about 30 min. An acupuncture needle ( 340 &micro;m) was inserted into the left ST-7 point (left masseter muscle) or the right LI-4 point after the first sampling and left for about 30 min (10 twists at 1 Hz, 2-min intervals). The mean blood flow of nine organs varied widely from 4.03 to 0.20 (ml/min/g). Acupuncture to the ST-7 produced significant changes of the blood flow (percentage change from baseline) in the muscle, kidney, brain and heart (<I>P</I> &lt; 0.05, versus control), but those of LI-4 were not significant. The blood flow of the left masseter muscle after acupuncture to ST-7 (left masseter muscle) tended to increase (<I>P</I> = 0.08). Changes in blood pressure during the experimental periods were almost similar among these three groups. Acupuncture stimulation increases the blood flow of several organs by modulating the central circulatory systems, and the effects differed with sites of stimulation.</p>
]]></description>
<dc:creator><![CDATA[Tsuru, H., Kawakita, K.]]></dc:creator>
<dc:date>Tue, 17 Feb 2009 07:15:24 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem068</dc:identifier>
<dc:title><![CDATA[Acupuncture on the Blood Flow of Various Organs Measured Simultaneously by Colored Microspheres in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>83</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>77</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/85?rss=1">
<title><![CDATA[Inhibitory Effects of Coptidis rhizoma and Berberine on Cocaine-induced Sensitization]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/85?rss=1</link>
<description><![CDATA[
<p>Substantial evidence suggests that the behavioral and reinforcing effects of cocaine can be mediated by the central dopaminergic systems. Repeated injections of cocaine produce an increase in locomotor activity and the expression of tyrosine hydroxylase (TH) in the main dopaminergic areas. Protoberberine alkaloids affect neuronal functions. <I>Coptidis rhizoma</I> (CR) and its main compound, berberine (BER) reduced the dopamine content in the central nervous system. In order to investigate the effects of CR or BER on the repeated cocaine-induced neuronal and behavioral alterations, we examined the influence of CR or BER on the repeated cocaine-induced locomotor activity and the expression of TH in the brain by using immunohistochemistry. Male SD rats were given repeated injections of saline or cocaine hydrochloride (15 mg/kg, i.p. for 10 consecutive days) followed by one challenge injection on the 4th day after the last daily injection. Cocaine challenge (15 mg/kg, i.p) produced a larger increase in locomotor activity and expression of TH in the central dopaminergic areas. Pretreatment with CR (50, 100, 200 and 400 mg/kg, p.o.) and BER (200 mg/kg, p.o.) 30 min before the daily injections of cocaine significantly inhibited the cocaine-induced locomotor activity as well as TH expression in the central dopaminergic areas. Our data demonstrate that the inhibitory effects of CR and BER on the repeated cocaine-induced locomotor activity were closely associated with the reduction of dopamine biosynthesis and post-synaptic neuronal activity. These results suggest that CR and BER may be effective for inhibiting the behavioral effects of cocaine by possibly modulating the central dopaminergic system.</p>
]]></description>
<dc:creator><![CDATA[Lee, B., Yang, C. H., Hahm, D.-H., Choe, E. S., Lee, H.-J., Pyun, K.-H., Shim, I.]]></dc:creator>
<dc:date>Tue, 17 Feb 2009 07:15:24 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem070</dc:identifier>
<dc:title><![CDATA[Inhibitory Effects of Coptidis rhizoma and Berberine on Cocaine-induced Sensitization]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>90</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>85</prism:startingPage>
<prism:section>Original Articles - Basic Science</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/91?rss=1">
<title><![CDATA[Regulation of Cellular Metabolism and Cytokines by the Medicinal Herb Feverfew in the Human Monocytic THP-1 Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/91?rss=1</link>
<description><![CDATA[
<p>The herb feverfew is a folk remedy for various symptoms including inflammation. Inflammation has recently been implicated in the genesis of many diseases including cancers, atherosclerosis and rheumatoid arthritis. The mechanisms of action of feverfew in the human body are largely unknown. To determine the cellular targets of feverfew extracts, we have utilized oligo microarrays to study the gene expression profiles elicited by feverfew extracts in human monocytic THP-1 cells. We have identified 400 genes that are consistently regulated by feverfew extracts. Most of the genes are involved in cellular metabolism. However, the genes undergoing the highest degree of change by feverfew treatment are involved in other pathways including chemokine function, water homeostasis and heme-mediated signaling. Our results also suggest that feverfew extracts effectively reduce Lipopolysaccharides (LPS)-mediated TNF- and CCL2 (MCP-1) releases by THP-1 cells. We hypothesize that feverfew components mediate metabolism, cell migration and cytokine production in human monocytes/macrophages.</p>
]]></description>
<dc:creator><![CDATA[Chen, C.-F., Cheng, C.-H.]]></dc:creator>
<dc:date>Tue, 17 Feb 2009 07:15:24 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem061</dc:identifier>
<dc:title><![CDATA[Regulation of Cellular Metabolism and Cytokines by the Medicinal Herb Feverfew in the Human Monocytic THP-1 Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>98</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>91</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/99?rss=1">
<title><![CDATA[Chinese Herbal Medicine for Dysfunctional Uterine Bleeding: a Meta-analysis]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/99?rss=1</link>
<description><![CDATA[
<p>We conducted a systematic review to evaluate the efficacy and safety of Chinese herbal medicine (CHM) for dysfunctional uterine bleeding (DUB) by performing a meta-analysis. Randomized controlled trials (RCTs) or quasi-RCTs comparing CHM vs no treatment, placebo, conventional western medicine (CWM), or general non-specific surgical treatment for DUB were identified by electronic and manual searches. Trials of CHM treatments with CWM treatments were compared with CWM treatments alone. Jadad scale and allocation concealment were used to assess the quality of included studies. Four RCTs or quasi-RCTs involving 525 patients were included. The methodological quality was poor in all trials except one trial. No serious adverse events were reported in the included studies. With the lack of trials comparing CHM with no treatment or placebo, it is impossible to accurately evaluate the efficacy of CHM. However, CHM in these studies seem to show an encouraging comparative effectiveness with CWM. More RCTs with a higher quality are required.</p>
]]></description>
<dc:creator><![CDATA[Tu, X., Huang, G., Tan, S.]]></dc:creator>
<dc:date>Tue, 17 Feb 2009 07:15:24 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem063</dc:identifier>
<dc:title><![CDATA[Chinese Herbal Medicine for Dysfunctional Uterine Bleeding: a Meta-analysis]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>105</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>99</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/107?rss=1">
<title><![CDATA[Variation Analysis of Sphygmogram to Assess Cardiovascular System under Meditation]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/107?rss=1</link>
<description><![CDATA[
<p>In this article, we studied how meditation affects the characteristics of the cardiovascular system, mainly based on blood pressure waveforms (BPW). Four parameters derived from BPW include the rising slope (<I>h</I><SUB>1</SUB>/<I>t</I><SUB>1</SUB>), normalized height of T wave (<I>h</I><SUB>3</SUB>/<I>h</I><SUB>1</SUB>), normalized height of <I>V</I><SUB>3</SUB> valley (<I>h</I><SUB>4</SUB>/<I>h</I><SUB>1</SUB>) and normalized height of D wave (<I>h</I><SUB>5</SUB>/<I>h</I><SUB>1</SUB>), where <I>t</I><SUB>1</SUB> and <I>h<SUB>i</SUB></I>, <I>i</I> = 1, ... ,5 are quantitative features of the BPW waveform pattern. A larger value of <I>h</I><SUB>1</SUB>/<I>t</I><SUB>1</SUB> reflects better heart ejection ability and aorta compliance. A larger value of <I>h</I><SUB>3</SUB>/<I>h</I><SUB>1</SUB> may infer an arterial system with good elasticity. The decrease (increase) of <I>h</I><SUB>4</SUB>/<I>h</I><SUB>1</SUB> parameter indicates the decrease (increase) of peripheral resistance of vessels. A larger value of <I>h</I><SUB>5</SUB>/<I>h</I><SUB>1</SUB> indicates better artery elasticity and aortic valve function. In comparison with the control group, Zen-meditation practitioners have more after-meditation <I>h</I><SUB>1</SUB>/<I>t</I><SUB>1</SUB>, <I>h</I><SUB>3</SUB>/<I>h</I><SUB>1</SUB> and <I>h</I><SUB>5</SUB>/<I>h</I><SUB>1</SUB> increase, with more <I>h</I><SUB>4</SUB>/<I>h</I><SUB>1</SUB> decrease, with statistical significance (<I>P</I> &lt; 0.05). The observation allows us to infer that Zen meditation may effectively improve relevant characteristics of the cardiovascular system.</p>
]]></description>
<dc:creator><![CDATA[Liu, C.-Y., Wei, C.-C., Lo, P.-C.]]></dc:creator>
<dc:date>Tue, 17 Feb 2009 07:15:24 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem065</dc:identifier>
<dc:title><![CDATA[Variation Analysis of Sphygmogram to Assess Cardiovascular System under Meditation]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>112</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>107</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/113?rss=1">
<title><![CDATA[Influence of Honey on the Suppression of Human Low Density Lipoprotein (LDL) Peroxidation (In vitro)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/113?rss=1</link>
<description><![CDATA[
<p>The antioxidant activity of four honey samples from different floral sources (Acacia, Coriander, Sider and Palm) were evaluated with three different assays; DPPH free radical scavenging assay, superoxide anion generated in xanthine&ndash;xanthine oxidase (XOD) system and low density lipoprotein (LDL) peroxidation assay. The dark Palm and Sider honeys had the highest antioxidant activity in the DPPH assay. But all the honey samples exhibited more or less the same highly significant antioxidant activity within the concentration of 1mg honey/1 ml in XOD system and LDL peroxidation assays. The chemical composition of these samples was investigated by GC/MS and HPLC analysis, 11 compounds being new to honey. The GC/MS revealed the presence of 90 compounds, mainly aliphatic acids (37 compounds), which represent 54.73, 8.72, 22.87 and 64.10% and phenolic acids (15 compound) 2.3, 1.02, 2.07 and 11.68% for Acacia, Coriander, Sider and Palm honeys. In HPLC analysis, 19 flavonoids were identified. Coriander and Sider honeys were characterized by the presence of large amounts of flavonoids.</p>
]]></description>
<dc:creator><![CDATA[Hegazi, A. G., Abd El-Hady, F. K.]]></dc:creator>
<dc:date>Tue, 17 Feb 2009 07:15:24 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem071</dc:identifier>
<dc:title><![CDATA[Influence of Honey on the Suppression of Human Low Density Lipoprotein (LDL) Peroxidation (In vitro)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>121</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>113</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/6/1/123?rss=1">
<title><![CDATA[Anxiolytic Effect of Aromatherapy Massage in Patients with Breast Cancer]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/6/1/123?rss=1</link>
<description><![CDATA[
<p>We examined how aromatherapy massage influenced psychologic and immunologic parameters in 12 breast cancer patients in an open semi-comparative trial. We compared the results 1 month before aromatherapy massage as a waiting control period with those during aromatherapy massage treatment and 1 month after the completion of aromatherapy sessions. The patients received a 30 min aromatherapy massage twice a week for 4 weeks (eight times in total). The results showed that anxiety was reduced in one 30 min aromatherapy massage in State-Trait Anxiety Inventory (STAI) test and also reduced in eight sequential aromatherapy massage sessions in the Hospital Anxiety and Depression Scale (HADS) test. Our results further suggested that aromatherapy massage ameliorated the immunologic state. Further investigations are required to confirm the anxiolytic effect of aromatherapy in breast cancer patients.</p>
]]></description>
<dc:creator><![CDATA[Imanishi, J., Kuriyama, H., Shigemori, I., Watanabe, S., Aihara, Y., Kita, M., Sawai, K., Nakajima, H., Yoshida, N., Kunisawa, M., Kawase, M., Fukui, K.]]></dc:creator>
<dc:date>Tue, 17 Feb 2009 07:15:24 PST</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem073</dc:identifier>
<dc:title><![CDATA[Anxiolytic Effect of Aromatherapy Massage in Patients with Breast Cancer]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>6</prism:volume>
<prism:endingPage>128</prism:endingPage>
<prism:publicationDate>2009-03-01</prism:publicationDate>
<prism:startingPage>123</prism:startingPage>
<prism:section>Original Articles - Clinical Analyses</prism:section>
</item>

</rdf:RDF>